Diala Alatassi MD

01/28/2026

Weightlifting outmuscles running for blood sugar control, study finds.

Running may help burn calories, but when it comes to preventing diabetes and obesity, pumping iron might have the edge, according to preclinical findings from the Fralin Biomedical Research Institute at VTC.

01/26/2026

Half of US adults resolve to start a new diet in 2026.

More than 80% of respondents said the cost of groceries is important when choosing a weight-loss plan, but only 6% say they'll try a plant-based or vegan diet, which research shows is among the least expensive and most effective for losing weight and keeping it off.

01/22/2026

A year of dieting with non-sugar sweeteners shows weight loss can stay lost.

Researchers at Maastricht University and the University of Copenhagen report that incorporating sweeteners and sweetness enhancers within a healthy, sugar-reduced diet supported one-year weight loss maintenance and coincided with microbiota shifts toward short-chain fatty acid and methane-produci...

01/19/2026

One short quiz could help people stick to their weight loss plans.

A new study, published in JMIR Formative Research, has found that people who answered a brief quiz to determine their "eating profile" were more likely to stick with their program and stay committed to their weight loss goals when offered personalized advice.

01/07/2026

Weight loss drug could help avoid need for follow-up bariatric surgery.

Combining bariatric surgery with weight loss medication can help people who need to lose more weight post-surgery, Monash University and Alfred Health-led research has found.

01/01/2026

Wishing you and your family a happy and healthy new year!

12/31/2025

New weight loss pill aims to bridge gap in obesity treatments.

An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers.

12/24/2025

GLP-1 and health: Beyond weight loss in the Ozempic era.

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these treatments for people with diabetes and obesity.

12/22/2025

Happy Holidays! We wish you and your family a joyful holiday season!

12/17/2025

Once-weekly eloralintide leads to 20% weight loss in Phase II trial.

A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without type 2 diabetes.

12/15/2025

Weight-loss surgery bests medical weight management for obesity-related risk mitigation.

Bariatric surgery is associated with a significantly lower risk for developing major metabolic comorbidities compared with a medical weight management program for adults with obesity, according to a study published online Sept. 9 in JAMA Network Open.

12/10/2025

Popular weight-loss drugs show added heart protection for diabetes patients.

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this result using insurance claims data.